Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-04 5:58 pm | N/A 2034-01-02 | Rallybio Corp | RLYB | PARMAR KUSH Director | 27,118 | $1.77 | 27,118 (Direct) | View |
Ownership | 2023-08-28 4:18 pm | N/A N/A | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 0 | $0 | 1,557,205,277 (Indirect) | View |
| 2023-06-08 Option Award | 2023-06-12 4:06 pm | N/A 2033-06-08 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 5:26 pm | N/A 2033-05-17 | Rallybio Corp | RLYB | PARMAR KUSH Director | 15,490 | $0 | 15,490 (Direct) | View |
Ownership | 2023-03-06 5:18 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH 10% Owner | 0 | $0 | 5,798,475 (Indirect) | View |
| 2023-02-24 Equity Swap | 2023-02-28 4:29 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 5AM Opportunities I (GP) LLC 10% Owner | 4,937,646 | $0 | 0 (Indirect) | View |
| 2023-01-03 Option Award | 2023-01-05 6:29 pm | N/A 2033-01-03 | Rallybio Corp | RLYB | PARMAR KUSH Director | 10,344 | $0 | 10,344 (Direct) | View |
| 2022-12-01 Disposition | 2022-12-02 4:49 pm | N/A 2032-06-22 | Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 0 (Direct) | View |
| 2022-11-30 Equity Swap | 2022-12-02 4:49 pm | N/A N/A | Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner | 4,135,786 | $0 | 0 (Indirect) | View |
| 2022-06-23 Option Award | 2022-06-27 5:02 pm | N/A 2032-06-22 | Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:05 pm | N/A 2032-06-15 | Homology Medicines Inc. | FIXX | PARMAR KUSH Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 5:09 pm | N/A 2032-06-13 | Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner | 16,911 | $0 | 16,911 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 4:01 pm | N/A 2032-06-02 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 11,918 | $0 | 11,918 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 8:08 pm | N/A 2032-05-24 | Rallybio Corp | RLYB | PARMAR KUSH Director | 13,440 | $0 | 13,440 (Direct) | View |
| 2022-01-11 Conversion | 2022-01-13 4:45 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 17,017,645 | $0 | 496,323 (Indirect) | View |
Ownership | 2022-01-06 9:02 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 0 | $0 | 3,867,646 (Indirect) | View |
| 2022-01-03 Option Award | 2022-01-05 8:38 pm | N/A 2032-01-03 | Rallybio Corp | RLYB | PARMAR KUSH Director | 5,772 | $0 | 5,772 (Direct) | View |
| 2021-11-02 Conversion | 2021-11-05 08:49 am | N/A N/A | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 3,827,224 | $0 | 1,132,357 (Indirect) | View |
Ownership(A) | 2021-11-05 08:48 am | N/A N/A | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 0 | $0 | 2,371,739 (Indirect) | View |
| 2021-10-28 Option Award | 2021-11-01 9:48 pm | N/A 2031-10-28 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 23,552 | $0 | 23,552 (Direct) | View |
Ownership | 2021-10-28 9:57 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 0 | $0 | 4,158,379 (Indirect) | View |
| 2021-07-28 Option Award | 2021-08-04 9:19 pm | N/A N/A | Rallybio Corp | RLYB | PARMAR KUSH Director | 13,440 | $0 | 4,994,878 (Direct) | View |
| 2021-07-28 Other | 2021-08-04 9:19 pm | N/A N/A | Rallybio Corp | RLYB | PARMAR KUSH Director | 26,341,690 | $0 | 4,994,878 (Indirect) | View |
Ownership | 2021-07-29 7:38 pm | N/A N/A | Rallybio Corp | RLYB | PARMAR KUSH Director 10% Owner | 0 | $0 | 3,588,780 (Indirect) | View |
| 2021-06-24 Option Award | 2021-06-25 4:38 pm | N/A 2031-06-23 | Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 5:40 pm | N/A 2031-06-17 | Homology Medicines Inc. | FIXX | PARMAR KUSH Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2021-04-27 Conversion | 2021-04-29 8:51 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner | 101,457 | $13.5 | 575,000 (Indirect) | View |
| 2021-04-27 Conversion | 2021-04-29 8:51 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner | 39,725,924 | $0 | 575,000 (Indirect) | View |
| 2021-04-22 Other | 2021-04-26 5:55 pm | N/A 2021-12-31 | IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 1,359,799 | $0 | 1,359,799 (Indirect) | View |